27 research outputs found

    THE ISSUE OF PREGNANCY AND DELIVERY WITH PRENATAL INFECTION OF THE FETUS, HEALTH STATUS OF BABIES ON THE FIRST YEARS OF LIFE

    Get PDF
    Pregnancy and delivery of 27 women with prenatal infection of the fetus, neonatal period of the babies with prenatal pneumonia, health status of up to 2 children were researched in retrospect. Women with inflammation of the genitals (78,6%) and extragenital pathology of the inflammatory genesis (36,3%) had prenatal infection of the fetus. In the early neonatal period every baby had cerebral ischemia, every third child had haemorrhages in different cerebral structures. All babies have been transferred to children's hospital for treatment where the rehabilitation was carried out during 1-2,5 months. Infantile cerebral paralysis, hydrocephaly, epilepsy, epileptoid attacks were detected in 8 babies on the first year of life (29,6%). 5 babies (18,5%) had atrophy of discs of optic nerves, retinal angiopathy. All babies with local pathology of the central nervous system were premature born on the 26-32 week. Majority has herniae of different localization (55,5%), congenital dysplasia of the hip joint (74%), 26 babies (96,2%) were on the books because of anaemiae, pneumoniae, bronchites, pyelonephrites, septicaemiae. Using the received data we can draw a conclusion: in order to reduce perinatal complications in the maternal organism, in the organism of newborn baby and baby on the first year of life it is necessary to sanify the birth canal, to do preclinical diagnostics and preventive therapy of the prematurely born, gestosis, fetoplacental insufficiency

    The HITRAN2020 Molecular Spectroscopic Database

    Get PDF
    The HITRAN database is a compilation of molecular spectroscopic parameters. It was established in the early 1970s and is used by various computer codes to predict and simulate the transmission and emission of light in gaseous media (with an emphasis on terrestrial and planetary atmospheres). The HITRAN compilation is composed of five major components: the line-by-line spectroscopic parameters required for high-resolution radiative-transfer codes, experimental infrared absorption cross-sections (for molecules where it is not yet feasible for representation in a line-by-line form), collision-induced absorption data, aerosol indices of refraction, and general tables (including partition sums) that apply globally to the data. This paper describes the contents of the 2020 quadrennial edition of HITRAN. The HITRAN2020 edition takes advantage of recent experimental and theoretical data that were meticulously validated, in particular, against laboratory and atmospheric spectra. The new edition replaces the previous HITRAN edition of 2016 (including its updates during the intervening years). All five components of HITRAN have undergone major updates. In particular, the extent of the updates in the HITRAN2020 edition range from updating a few lines of specific molecules to complete replacements of the lists, and also the introduction of additional isotopologues and new (to HITRAN) molecules: SO, CH3F, GeH4, CS2, CH3I and NF3. Many new vibrational bands were added, extending the spectral coverage and completeness of the line lists. Also, the accuracy of the parameters for major atmospheric absorbers has been increased substantially, often featuring sub-percent uncertainties. Broadening parameters associated with the ambient pressure of water vapor were introduced to HITRAN for the first time and are now available for several molecules. The HITRAN2020 edition continues to take advantage of the relational structure and efficient interface available at www.hitran.org and the HITRAN Application Programming Interface (HAPI). The functionality of both tools has been extended for the new edition

    Experimental progress in positronium laser physics

    Get PDF

    The prospect of creating medicines based on selenium nanoparticles (Review)

    No full text
    Introduction. The prospects of using nanoparticles in the production of medicines are widely discussed in the literature. In 2018 alone, the quantity of registration certificates issued by national regulators for medicines that use nanoparticles in one form or another is around forty. Most of them are medicines based on liposomes, polymers, iron oxides, micelles. So far, no registration certificates have been issued for selenium nanoparticles. One of the reasons for this situation in this area, from our point of view, is that the mechanisms of interaction of nanoparticles with cells are not sufficiently studied. The lack of basic research in this area is one of the main obstacles to the development of new-generation drugs based on nanoparticles. Text. This review is devoted to the analysis of scientific data on the interaction of selenium nanoparticles with different types of cells. The article discusses the biological properties of selenium and its role in cell metabolism. Data on the cytotoxic effect of selenium nanoparticles on various cell cultures are presented. Methods of preparation of nanoparticles and methods for studying the interaction of nanoparticles with cell cultures are described. Conclusion. Analysis of the literature data allows us to draw conclusions about the relevance of research on the interaction of selenium nanoparticles with living cells. This is necessary to determine the mechanisms of selenium nanoparticles absorption, study their cytotoxic and / or cytostatic action, and distribution in cells. Investigation of the biological interaction of selenium nanoparticles with tumor and normal cells will determine the most informative methods for registering and quantifying their antitumor activity, which is relevant for the development of new drugs to treat cancer. Β© Skorinova K. D., Kuzmenko V. V., Vasilenko I. A., 2020

    АкнС: соврСмСнныС ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Ρ‹ ΠΊ Ρ€Π΅ΡˆΠ΅Π½ΠΈΡŽ старой ΠΏΡ€ΠΎΠ±Π»Π΅ΠΌΡ‹

    No full text
    Background. Acne is one of the most common chronic dermatoses, which occurs in almost 8590% of the population. The disease manifests itself as polymorphic eruptions and is characterized by a recurrent and torpid course. Acne treatment is constantly improving, requires an integrated approach and long courses of therapy. Aims. To increase the effectiveness of acne therapy using new opportunities and promising methodological approaches using a combination of the therapeutic effects of platelet-rich plasma (PRP) and topical bacteriophage therapy. Materials and methods. The study included 30 patients with papulopustular acne of mild and moderate severity. Patients with mild acne were treated with PRP procedures as monotherapy. For moderate acne, PRP therapy was combined with regular applications of a staphylococcal bacteriophage (NPO Microgen, Nizhny Novgorod, Russia). The treatment was carried out on an outpatient basis: at least 3 procedures with an interval of 12 weeks (up to a maximum of 6 procedures within one year). The results were analyzed using descriptive statistics and the parametric Student's t-test. Data processing was carried out using the Biostat software. The value of the level of statistical significance of differences was taken as p 0.05. Results. Evaluation of the effectiveness of treatment was carried out on the basis of an analysis of the immediate outcomes of the disease, the dynamics of clinical symptoms and the severity of acne: regression of inflammatory elements of acne, a decrease in the phenomenon of seborrhea, improvement of the skin relief. As a result of the therapy, a transition to remission was noted in 16.6% of patients, an improvement in their condition 36.7%, a significant improvement 46.7%. Conclusions. An integrated approach combining PRP procedures and bacteriophage therapy can serve as a pathogenetically substantiated strategy for treating acne. A promising direction for further research is the development of new regimens and combinations of alternative therapeutic strategies using bacteriophages.ОбоснованиС. АкнС ΠΎΠ΄ΠΈΠ½ ΠΈΠ· Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ распространСнных хроничСских Π΄Π΅Ρ€ΠΌΠ°Ρ‚ΠΎΠ·ΠΎΠ², ΠΊΠΎΡ‚ΠΎΡ€Ρ‹ΠΉ встрСчаСтся практичСски Ρƒ 8590% насСлСния. Π—Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ проявляСтся ΠΏΠΎΠ»ΠΈΠΌΠΎΡ€Ρ„Π½Ρ‹ΠΌΠΈ высыпаниями ΠΈ отличаСтся Ρ€Π΅Ρ†ΠΈΠ΄ΠΈΠ²ΠΈΡ€ΡƒΡŽΡ‰ΠΈΠΌ ΠΈ Ρ‚ΠΎΡ€ΠΏΠΈΠ΄Π½Ρ‹ΠΌ Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ΠΌ. Π›Π΅Ρ‡Π΅Π½ΠΈΠ΅ Π°ΠΊΠ½Π΅ постоянно ΡΠΎΠ²Π΅Ρ€ΡˆΠ΅Π½ΡΡ‚Π²ΡƒΠ΅Ρ‚ΡΡ, Ρ‚Ρ€Π΅Π±ΡƒΠ΅Ρ‚ комплСксного ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Π° ΠΈ Π΄Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… курсов Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ. ЦСль исслСдования. ΠŸΠΎΠ²Ρ‹ΡΠΈΡ‚ΡŒ ΡΡ„Ρ„Π΅ΠΊΡ‚ΠΈΠ²Π½ΠΎΡΡ‚ΡŒ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π°ΠΊΠ½Π΅, ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΡƒΡ Π½ΠΎΠ²Ρ‹Π΅ возмоТности ΠΈ пСрспСктивныС мСтодичСскиС ΠΏΠΎΠ΄Ρ…ΠΎΠ΄Ρ‹ Π² ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Ρ†ΠΈΠΈ с Π»Π΅Ρ‡Π΅Π±Π½Ρ‹ΠΌ воздСйствиСм ΠΏΠ»Π°Π·ΠΌΡ‹, ΠΎΠ±ΠΎΠ³Π°Ρ‰Π΅Π½Π½ΠΎΠΉ Ρ‚Ρ€ΠΎΠΌΠ±ΠΎΡ†ΠΈΡ‚Π°ΠΌΠΈ, ΠΈ топичСской Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠ΅ΠΉ. ΠœΠ΅Ρ‚ΠΎΠ΄Ρ‹. Π’ исслСдованиС Π±Ρ‹Π»ΠΈ Π²ΠΊΠ»ΡŽΡ‡Π΅Π½Ρ‹ 30 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с ΠΏΠ°ΠΏΡƒΠ»ΠΎ-пустулСзной Ρ„ΠΎΡ€ΠΌΠΎΠΉ Π°ΠΊΠ½Π΅ Π»Π΅Π³ΠΊΠΎΠΉ ΠΈ срСднСй стСпСни тяТСсти. ΠŸΠ°Ρ†ΠΈΠ΅Π½Ρ‚Π°ΠΌ с Π°ΠΊΠ½Π΅ Π»Π΅Π³ΠΊΠΎΠΉ стСпСни тяТСсти Π² качСствС ΠΌΠΎΠ½ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΠΈ Π½Π°Π·Π½Π°Ρ‡Π°Π»ΠΈ PRP-ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€Ρ‹. ΠŸΡ€ΠΈ Π°ΠΊΠ½Π΅ срСднСй стСпСни тяТСсти PRP-Ρ‚Π΅Ρ€Π°ΠΏΠΈΡŽ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡ€ΠΎΠ²Π°Π»ΠΈ с рСгулярными аппликациями ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚ΠΎΠΌ Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³Π° стафилококкового (НПО ΠœΠΈΠΊΡ€ΠΎΠ³Π΅Π½, НиТний Новгород, Россия). Π›Π΅Ρ‡Π΅Π½ΠΈΠ΅ ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π°ΠΌΠ±ΡƒΠ»Π°Ρ‚ΠΎΡ€Π½ΠΎ: Π½Π΅ ΠΌΠ΅Π½Π΅Π΅ 3 ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€ с ΠΈΠ½Ρ‚Π΅Ρ€Π²Π°Π»ΠΎΠΌ 12 Π½Π΅Π΄Π΅Π»ΠΈ (максимально Π΄ΠΎ 6 ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€ Π² Ρ‚Π΅Ρ‡Π΅Π½ΠΈΠ΅ ΠΎΠ΄Π½ΠΎΠ³ΠΎ Π³ΠΎΠ΄Π°). Анализ ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½Π½Ρ‹Ρ… Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ с использованиСм ΠΎΠΏΠΈΡΠ°Ρ‚Π΅Π»ΡŒΠ½ΠΎΠΉ статистики ΠΈ ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ парамСтричСского t-критСрия Π‘Ρ‚ΡŒΡŽΠ΄Π΅Π½Ρ‚Π°. ΠžΠ±Ρ€Π°Π±ΠΎΡ‚ΠΊΡƒ Π΄Π°Π½Π½Ρ‹Ρ… осущСствляли с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΡ‹ Biostat. Π—Π° Π²Π΅Π»ΠΈΡ‡ΠΈΠ½Ρƒ уровня статистичСской значимости Ρ€Π°Π·Π»ΠΈΡ‡ΠΈΠΉ ΠΏΡ€ΠΈΠ½ΠΈΠΌΠ°Π»ΠΈ p 0,05. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠžΡ†Π΅Π½ΠΊΡƒ эффСктивности лСчСния ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π½Π° основании Π°Π½Π°Π»ΠΈΠ·Π° Π±Π»ΠΈΠΆΠ°ΠΉΡˆΠΈΡ… исходов заболСвания, Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ клиничСских симптомов ΠΈ стСпСни тяТСсти Π°ΠΊΠ½Π΅: рСгрСсса Π²ΠΎΡΠΏΠ°Π»ΠΈΡ‚Π΅Π»ΡŒΠ½Ρ‹Ρ… элСмСнтов ΡƒΠ³Ρ€Π΅Π²ΠΎΠΉ сыпи, сниТСния явлСния сСборСи, ΡƒΠ»ΡƒΡ‡ΡˆΠ΅Π½ΠΈΡ ΠΊΠΎΠΆΠ½ΠΎΠ³ΠΎ Ρ€Π΅Π»ΡŒΠ΅Ρ„Π°. Π’ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π΅ ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠΌΠΎΠΉ Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ ΠΏΠ΅Ρ€Π΅Ρ…ΠΎΠ΄ Π² Ρ€Π΅ΠΌΠΈΡΡΠΈΡŽ ΠΎΡ‚ΠΌΠ΅Ρ‡Π΅Π½ Ρƒ 16,6% ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ², ΡƒΠ»ΡƒΡ‡ΡˆΠ΅Π½ΠΈΠ΅ состояния Ρƒ 36,7%, Π·Π½Π°Ρ‡ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ ΡƒΠ»ΡƒΡ‡ΡˆΠ΅Π½ΠΈΠ΅ Ρƒ 46,7%. Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. ΠŸΠ°Ρ‚ΠΎΠ³Π΅Π½Π΅Ρ‚ΠΈΡ‡Π΅ΡΠΊΠΈ обоснованной стратСгиСй лСчСния Π°ΠΊΠ½Π΅ ΠΌΠΎΠΆΠ΅Ρ‚ ΡΠ»ΡƒΠΆΠΈΡ‚ΡŒ комплСксный ΠΏΠΎΠ΄Ρ…ΠΎΠ΄, ΡΠΎΡ‡Π΅Ρ‚Π°ΡŽΡ‰ΠΈΠΉ PRP-ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€Ρ‹ ΠΈ Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΡ‚Π΅Ρ€Π°ΠΏΠΈΡŽ. ΠŸΠ΅Ρ€ΡΠΏΠ΅ΠΊΡ‚ΠΈΠ²Π½Ρ‹ΠΌ Π½Π°ΠΏΡ€Π°Π²Π»Π΅Π½ΠΈΠ΅ΠΌ Π΄Π°Π»ΡŒΠ½Π΅ΠΉΡˆΠΈΡ… исслСдований являСтся Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠ° Π½ΠΎΠ²Ρ‹Ρ… Ρ€Π΅ΠΆΠΈΠΌΠΎΠ² ΠΈ ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Ρ†ΠΈΠΉ Π°Π»ΡŒΡ‚Π΅Ρ€Π½Π°Ρ‚ΠΈΠ²Π½Ρ‹Ρ… тСрапСвтичСских стратСгий с ΠΏΡ€ΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ Π±Π°ΠΊΡ‚Π΅Ρ€ΠΈΠΎΡ„Π°Π³ΠΎΠ²

    Prevention of thrombohemorrhagic postoperative complications in patients with benign prostatic hyperplasia

    No full text
    AIM: To improve the results of surgical treatment of benign prostatic hyperplasia.MATERIALS AND METHODS: The study investigated the effectiveness of a comprehensive preoperative preparation of patients with benign prostatic hyperplasia. The clinical efficacy of traditional methods of preoperative preparation (compression bandaging of the lower extremities during surgery and in the postoperative period and Fraxiparine at a prophylactic dose) was compared with the same preoperative protocol used in combination with intravenous laser blood irradiation. The explored parameters included changes in clinical and laboratory coagulation indices and prostatic blood flow measured by Doppler sonography. The real time visualization was used to assess the effect of intravenous laser irradiation of blood on the morphofunctional state of platelets.CONCLUSION: The study findings showed a high effectiveness of intravenous laser blood irradiation in preoperative preparation of patients with benign prostatic hyperplasia. It was found to reduce the incidence of thrombotic events by 6% and hemorrhagic complications by 4.9% (p<0.05)

    Prevention of thrombohemorrhagic postoperative complications in patients with benign prostatic hyperplasia

    No full text
    AIM: To improve the results of surgical treatment of benign prostatic hyperplasia.MATERIALS AND METHODS: The study investigated the effectiveness of a comprehensive preoperative preparation of patients with benign prostatic hyperplasia. The clinical efficacy of traditional methods of preoperative preparation (compression bandaging of the lower extremities during surgery and in the postoperative period and Fraxiparine at a prophylactic dose) was compared with the same preoperative protocol used in combination with intravenous laser blood irradiation. The explored parameters included changes in clinical and laboratory coagulation indices and prostatic blood flow measured by Doppler sonography. The real time visualization was used to assess the effect of intravenous laser irradiation of blood on the morphofunctional state of platelets.CONCLUSION: The study findings showed a high effectiveness of intravenous laser blood irradiation in preoperative preparation of patients with benign prostatic hyperplasia. It was found to reduce the incidence of thrombotic events by 6% and hemorrhagic complications by 4.9% (p<0.05)

    ΠžΡ†Π΅Π½ΠΊΠ° Ρ„Π΅Π½ΠΎΡ‚ΠΈΠΏΠ° ΠΈΠ½Ρ‚Π΅Ρ€Ρ„Π°Π·Π½Ρ‹Ρ… ядСр Π»ΠΈΠΌΡ„ΠΎΡ†ΠΈΡ‚ΠΎΠ² ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ количСствСнного Ρ„Π°Π·ΠΎΠ²ΠΎΠ³ΠΎ ΠΈΠΌΠΈΠ΄ΠΆΠΈΠ½Π³Π° (QPI) Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ с эндомСтриоидными кистами яичников

    No full text
    Rationale: Ovarian endometriosis is a progressive disease with growing prevalence and severity. Therefore, the development of robust non-invasive laboratory screening methods for early diagnosis on the out-patient basis seems quite relevant. Aim: To assess a potential of the quantitative phase imaging technique for early diagnosis of ovarian endometrial cysts and post-operative relapses of the disease. Materials and methods: We analyzed 1578 nuclei of the peripheral blood lymphocytes from 82 patients with ovarian endometrial cysts, aged 21 to 37 years (mean age 26.4 Β± 3.6 years). The patients were follow-up in a gynecology out-patient clinic (the town of Yessentuki, Russia). Assessments were made longitudinally, i.e., before a laparoscopic cystectomy, at 6 and 12 months in the post-operative period with or without treatment with dienogest-containing agents. Morphological and functional status of the nuclei from the peripheral blood lymphocytes was assessed in the real-time mode by quantitative phase imaging (QPI) with the phase-interference microscopy module of the Bioni hardware and software complex (Westgrade Ltd., Moscow) for clinical and laboratory diagnostics, and the morphodensitometric segmentation technology. Results: The comparative analysis of morphometric parameters of CD3sup+/sup cells taken from peripheral blood of healthy non-pregnant women and patients with ovarian endometrial cysts before surgery showed a significant increase of the calculated functional activities of the lymphocyte nuclei (0.898 vs 0.783, p 0.05). Assessment of changes overt time in the differential diagnostic criteria of the nuclear response in the peripheral blood lymphocytes from patients with endometrial ovarian cysts showed the following. Compared to the parameters obtained before treatment, at 6 and 12 months of the post-operative period the relative intensity of nuclear segments (Ξ”I) decreased by 10.3 and 14.7, 10.6 and 12.9% in the group treated with and without dienogest, respectively. Relative distance between the centers of the nuclear segments (Ξ”L) demonstrated a trend towards an increase by 0.6 and 0.9, 4.2 and 2.1%. The numbers of nuclear segments increased by 18.3 and 13.4, 27.4 and 16.9%, whereas the nuclear perimeter decreased by 13.9 and 12.6, 11.9 and 7.8%, respectively. In the patients treated with dienogest, the rate of non-relapse at 6 and 12 months of the follow-up was 100%, whereas in the patients without dienogest therapy, 97.5 and 93.5%, respectively. Discussion: Interphase chromatin is a unique biosensor of the early abnormalities in a lymphoid cell. Modification of its structure and packaging density not only indicate changes of the morphofunctional status of the lymphocyte, but can be projected to the body as a whole and used for early pre-clinical diagnosis, assessment of severity of the pathological process and prediction of the outcome in various critic states. Conclusion: Practical implementation of QPI for clinical monitoring of patients with ovarian endometrial cysts makes it possible to obtain important information on the cell immunity in real time. It opens new opportunities to assess the efficacy of treatment and rehabilitation activities, as well as for early pre-clinical diagnosis of relapsing disease.Β ΠΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ. Π­Π½Π΄ΠΎΠΌΠ΅Ρ‚Ρ€ΠΈΠΎΠ· яичников – ΠΏΡ€ΠΎΠ³Ρ€Π΅ΡΡΠΈΡ€ΡƒΡŽΡ‰Π΅Π΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅, Ρ€Π°ΡΠΏΡ€ΠΎΡΡ‚Ρ€Π°Π½Π΅Π½Π½ΠΎΡΡ‚ΡŒ ΠΈ Ρ‚ΡΠΆΠ΅ΡΡ‚ΡŒ ΠΊΠΎΡ‚ΠΎΡ€ΠΎΠ³ΠΎ Π½Π΅ΡƒΠΊΠ»ΠΎΠ½Π½ΠΎ Π²ΠΎΠ·Ρ€Π°ΡΡ‚Π°ΡŽΡ‚. Π’ связи с этим ΠΏΡ€Π΅Π΄ΡΡ‚Π°Π²Π»ΡΡŽΡ‚ΡΡ Π°ΠΊΡ‚ΡƒΠ°Π»ΡŒΠ½Ρ‹ΠΌΠΈ вопросы Ρ€Π°Π·Ρ€Π°Π±ΠΎΡ‚ΠΊΠΈ Π½Π°Π΄Π΅ΠΆΠ½Ρ‹Ρ… Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½Ρ‹Ρ… скрининговых ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ² Π»Π°Π±ΠΎΡ€Π°Ρ‚ΠΎΡ€Π½ΠΎΠΉ диагностики заболСвания Π½Π° этапС Ρ€Π°Π½Π½Π΅Π³ΠΎ Π°ΠΌΠ±ΡƒΠ»Π°Ρ‚ΠΎΡ€Π½ΠΎΠ³ΠΎ обслСдования. ЦСль – ΠΎΡ†Π΅Π½ΠΊΠ° возмоТностСй ΠΌΠ΅Ρ‚ΠΎΠ΄Π° количСствСнного Ρ„Π°Π·ΠΎΠ²ΠΎΠ³ΠΎ ΠΈΠΌΠΈΠ΄ΠΆΠΈΠ½Π³Π° для Ρ€Π°Π½Π½Π΅ΠΉ диагностики эндомСтриоидных кист яичников ΠΈ Ρ€Π΅Ρ†ΠΈΠ΄ΠΈΠ²ΠΎΠ² заболСвания Π² послСопСрационном ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅. ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π» ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹. ΠŸΡ€ΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡ€ΠΎΠ²Π°Π½Ρ‹ 1578 ядСр Π»ΠΈΠΌΡ„ΠΎΡ†ΠΈΡ‚ΠΎΠ² пСрифСричСской ΠΊΡ€ΠΎΠ²ΠΈ 82 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ с эндомСтриоидными кистами яичников Π² возрастС ΠΎΡ‚ 21 Π΄ΠΎ 37 Π»Π΅Ρ‚ (срСдний возраст 26,4 Β± 3,6 Π³ΠΎΠ΄Π°), Π½Π°Π±Π»ΡŽΠ΄Π°Π²ΡˆΠΈΡ…ΡΡ Π² ТСнской ΠΊΠΎΠ½ΡΡƒΠ»ΡŒΡ‚Π°Ρ†ΠΈΠΈ (Π³. ЕссСнтуки). ИсслСдования ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π² Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ΅: Π΄ΠΎ лапароскопичСской цистэктомии, Ρ‡Π΅Ρ€Π΅Π· 6 ΠΈ 12 мСсяцСв послСопСрационного ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π° Π½Π° Ρ„ΠΎΠ½Π΅ ΠΈΠ»ΠΈ Π±Π΅Π· лСчСния ΠΏΡ€Π΅ΠΏΠ°Ρ€Π°Ρ‚Π°ΠΌΠΈ с Π΄Π΅ΠΉΡΡ‚Π²ΡƒΡŽΡ‰ΠΈΠΌ вСщСством диСногСст. ΠœΠΎΡ€Ρ„ΠΎΡ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ΅ состояниС ядСр Π»ΠΈΠΌΡ„ΠΎΡ†ΠΈΡ‚ΠΎΠ² пСрифСричСской ΠΊΡ€ΠΎΠ²ΠΈ ΠΎΡ†Π΅Π½ΠΈΠ²Π°Π»ΠΈ Π² Ρ€Π΅ΠΆΠΈΠΌΠ΅ Ρ€Π΅Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ Π²Ρ€Π΅ΠΌΠ΅Π½ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ количСствСнного Ρ„Π°Π·ΠΎΠ²ΠΎΠ³ΠΎ ΠΈΠΌΠΈΠ΄ΠΆΠΈΠ½Π³Π° (QPI) с использованиСм модуля Ρ„Π°Π·ΠΎΠ²ΠΎ-ΠΈΠ½Ρ‚Π΅Ρ€Ρ„Π΅Ρ€Π΅Π½Ρ†ΠΈΠΎΠ½Π½ΠΎΠΉ микроскопии Π°ΠΏΠΏΠ°Ρ€Π°Ρ‚Π½ΠΎ-ΠΏΡ€ΠΎΠ³Ρ€Π°ΠΌΠΌΠ½ΠΎΠ³ΠΎ комплСкса Β«Π‘ΠΈΠΎΠ½ΠΈΒ» (ООО «ВСсттрСйд», Москва) для клиничСской ΠΈ Π»Π°Π±ΠΎΡ€Π°Ρ‚ΠΎΡ€Π½ΠΎΠΉ диагностики, Π° Ρ‚Π°ΠΊΠΆΠ΅ Ρ‚Π΅Ρ…Π½ΠΎΠ»ΠΎΠ³ΠΈΠΈ морфодСнситомСтричСской сСгмСнтации. Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠŸΡ€ΠΈ ΡΡ€Π°Π²Π½ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΌ Π°Π½Π°Π»ΠΈΠ·Π΅ морфомСтричСских ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»Π΅ΠΉ CD3+-ΠΊΠ»Π΅Ρ‚ΠΎΠΊ пСрифСричСской ΠΊΡ€ΠΎΠ²ΠΈ соматичСски Π·Π΄ΠΎΡ€ΠΎΠ²Ρ‹Ρ… Π½Π΅Π±Π΅Ρ€Π΅ΠΌΠ΅Π½Π½Ρ‹Ρ… ΠΆΠ΅Π½Ρ‰ΠΈΠ½ ΠΈ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ с эндомСтриоидными кистами яичников Π΄ΠΎ провСдСния ΠΈΠΌ ΠΎΠΏΠ΅Ρ€Π°Ρ‚ΠΈΠ²Π½ΠΎΠ³ΠΎ лСчСния выявлСно статистичСски Π·Π½Π°Ρ‡ΠΈΠΌΠΎΠ΅ ΠΏΠΎΠ²Ρ‹ΡˆΠ΅Π½ΠΈΠ΅ расчСтного показатСля Ρ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠΉ активности ядСр Π»ΠΈΠΌΡ„ΠΎΡ†ΠΈΡ‚ΠΎΠ² (0,898 ΠΏΡ€ΠΎΡ‚ΠΈΠ² 0,783, p 0,05). ИсслСдованиС Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ Π΄ΠΈΡ„Ρ„Π΅Ρ€Π΅Π½Ρ†ΠΈΠ°Π»ΡŒΠ½ΠΎ-диагностичСских ΠΊΡ€ΠΈΡ‚Π΅Ρ€ΠΈΠ΅Π² Ρ€Π΅Π°ΠΊΡ‚ΠΈΠ²Π½Ρ‹Ρ… ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ ядСр Π»ΠΈΠΌΡ„ΠΎΡ†ΠΈΡ‚ΠΎΠ² пСрифСричСской ΠΊΡ€ΠΎΠ²ΠΈ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ с эндомСтриоидными кистами яичников ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ: ΠΏΠΎ ΡΡ€Π°Π²Π½Π΅Π½ΠΈΡŽ с Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌΠΈ Π΄ΠΎ лСчСния Π½Π° 6-ΠΌ ΠΈ 12-ΠΌ мСсяцах послСопСрационного ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π° Π²Π΅Π»ΠΈΡ‡ΠΈΠ½Π° ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ интСнсивности сСгмСнтов Π² ядрах (Ξ”I) сниТалась Π½Π° 10,3 ΠΈ 14,7, 10,6 ΠΈ 12,9% Π² Π³Ρ€ΡƒΠΏΠΏΠ°Ρ…, ΠΏΠΎΠ»ΡƒΡ‡Π°Π²ΡˆΠΈΡ… Ρ‚Π΅Ρ€Π°ΠΏΠΈΡŽ диСногСстом, ΠΈ Π±Π΅Π· Ρ‚Π΅Ρ€Π°ΠΏΠΈΠΈ диСногСстом соотвСтствСнно; ΠΎΡ‚Π½ΠΎΡΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ΅ расстояниС ΠΌΠ΅ΠΆΠ΄Ρƒ Ρ†Π΅Π½Ρ‚Ρ€Π°ΠΌΠΈ сСгмСнтов ядСр (Ξ”L) ΠΈΠΌΠ΅Π»ΠΎ Ρ‚Π΅Π½Π΄Π΅Π½Ρ†ΠΈΡŽ ΠΊ ΡƒΠ²Π΅Π»ΠΈΡ‡Π΅Π½ΠΈΡŽ Π½Π° 0,6 ΠΈ 0,9, 4,2 ΠΈ 2,1%; количСство сСгмСнтов Π² ядрах ΡƒΠ²Π΅Π»ΠΈΡ‡ΠΈΠ²Π°Π»ΠΎΡΡŒ Π½Π° 18,3 ΠΈ 13,4, 27,4 ΠΈ 16,9%; ΠΏΠ΅Ρ€ΠΈΠΌΠ΅Ρ‚Ρ€ ядСр ΡƒΠΌΠ΅Π½ΡŒΡˆΠ°Π»ΡΡ Π½Π° 13,9 ΠΈ 12,6, 11,9 ΠΈ 7,8% соотвСтствСнно. Частота Π±Π΅Π·Ρ€Π΅Ρ†ΠΈΠ΄ΠΈΠ²Π½Ρ‹Ρ… случаСв Ρ‡Π΅Ρ€Π΅Π· 6 ΠΈ 12 мСсяцСв наблюдСния Π² Π³Ρ€ΡƒΠΏΠΏΠ°Ρ… Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ…, ΠΏΠΎΠ»ΡƒΡ‡Π°Π²ΡˆΠΈΡ… диСногСст, составила 100%, Ρ‚ΠΎΠ³Π΄Π° ΠΊΠ°ΠΊ Ρƒ ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΊ, Π½Π΅ ΠΏΠΎΠ»ΡƒΡ‡Π°Π²ΡˆΠΈΡ… Π»Π΅Ρ‡Π΅Π½ΠΈΠ΅ диСногСстом, – 97,5 ΠΈ 93,5% соотвСтствСнно. ΠžΠ±ΡΡƒΠΆΠ΄Π΅Π½ΠΈΠ΅. Π˜Π½Ρ‚Π΅Ρ€Ρ„Π°Π·Π½Ρ‹ΠΉ Ρ…Ρ€ΠΎΠΌΠ°Ρ‚ΠΈΠ½ прСдставляСт собой своСобразный биосСнсор, Π΄Π°Ρ‚Ρ‡ΠΈΠΊ Ρ€Π°Π½Π½ΠΈΡ… ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π»ΠΈΠΌΡ„ΠΎΠΈΠ΄Π½ΠΎΠΉ ΠΊΠ»Π΅Ρ‚ΠΊΠΈ. ΠœΠΎΠ΄ΠΈΡ„ΠΈΠΊΠ°Ρ†ΠΈΠΈ Π΅Π³ΠΎ структуры ΠΈ плотности ΡƒΠΏΠ°ΠΊΠΎΠ²ΠΊΠΈ Π½Π΅ Ρ‚ΠΎΠ»ΡŒΠΊΠΎ ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΡƒΡŽΡ‚ ΠΎΠ± ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΈ ΠΌΠΎΡ€Ρ„ΠΎΡ„ΡƒΠ½ΠΊΡ†ΠΈΠΎΠ½Π°Π»ΡŒΠ½ΠΎΠ³ΠΎ состояния Π»ΠΈΠΌΡ„ΠΎΡ†ΠΈΡ‚Π°, Π½ΠΎ ΠΈ ΠΌΠΎΠ³ΡƒΡ‚ Π±Ρ‹Ρ‚ΡŒ спроСцированы Π½Π° ΠΎΡ€Π³Π°Π½ΠΈΠ·ΠΌ Π² Ρ†Π΅Π»ΠΎΠΌ для Ρ€Π°Π½Π½Π΅ΠΉ доклиничСской диагностики, ΠΎΡ†Π΅Π½ΠΊΠΈ тяТСсти патологичСского процСсса ΠΈ ΠΏΡ€ΠΎΠ³Π½ΠΎΠ·Π° ΠΏΡ€ΠΈ Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… кризисных состояниях. Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. ΠŸΡ€Π°ΠΊΡ‚ΠΈΡ‡Π΅ΡΠΊΠΎΠ΅ использованиС QPI Π² клиничСском ΠΌΠΎΠ½ΠΈΡ‚ΠΎΡ€ΠΈΠ½Π³Π΅ Π±ΠΎΠ»ΡŒΠ½Ρ‹Ρ… с эндомСтриоидными кистами яичников способствуСт ΠΎΠΏΠ΅Ρ€Π°Ρ‚ΠΈΠ²Π½ΠΎΠΌΡƒ ΠΏΠΎΠ»ΡƒΡ‡Π΅Π½ΠΈΡŽ Π²Π°ΠΆΠ½ΠΎΠΉ ΠΈΠ½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈ ΠΎ состоянии ΠΊΠ»Π΅Ρ‚ΠΎΡ‡Π½ΠΎΠ³ΠΎ Π·Π²Π΅Π½Π° ΠΈΠΌΠΌΡƒΠ½ΠΈΡ‚Π΅Ρ‚Π°, ΠΎΡ‚ΠΊΡ€Ρ‹Π²Π°Π΅Ρ‚ Π½ΠΎΠ²Ρ‹Π΅ возмоТности для ΠΎΡ†Π΅Π½ΠΊΠΈ эффСктивности ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠΌΡ‹Ρ… Π»Π΅Ρ‡Π΅Π±Π½Ρ‹Ρ… ΠΈ Ρ€Π΅Π°Π±ΠΈΠ»ΠΈΡ‚Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹Ρ… мСроприятий, Π° Ρ‚Π°ΠΊΠΆΠ΅ Ρ€Π°Π½Π½Π΅ΠΉ доклиничСской диагностики Ρ€Π΅Ρ†ΠΈΠ΄ΠΈΠ²Π° заболСвания
    corecore